Clinical Trial Update: Heart Failure Re-admission Risk Estimation Using NICaS System With Comparison to Serum BNP Levels [NA]

View source ↗

Summary

A completed clinical trial evaluating the NICaS System for estimating readmission risk in heart failure patients, comparing its performance to serum BNP levels.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Heart Failure | NA | Status: COMPLETED